gefitinib has been researched along with xanthenes in 2 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (xanthenes) | Trials (xanthenes) | Recent Studies (post-2010) (xanthenes) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 5,020 | 92 | 1,325 |
| Protein | Taxonomy | gefitinib (IC50) | xanthenes (IC50) |
|---|---|---|---|
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 7.42 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ellerbrok, H; Koban, R; Langhammer, S; Yue, C | 1 |
| Carrillo, V; Dubisz, E; Gulzar, H; Mahajan, SS; Morgan, D; Yelskaya, Z | 1 |
2 other study(ies) available for gefitinib and xanthenes
| Article | Year |
|---|---|
Inhibition of poxvirus spreading by the anti-tumor drug Gefitinib (Iressa).
Topics: Antiviral Agents; Cell Line; Cell Proliferation; ErbB Receptors; Gefitinib; Humans; Microbial Sensitivity Tests; Oxazines; Quinazolines; Vaccinia virus; Viral Plaque Assay; Xanthenes | 2011 |
Synergistic inhibition of survival, proliferation, and migration of U87 cells with a combination of LY341495 and Iressa.
Topics: Amino Acids; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Gefitinib; Glioblastoma; Glutamic Acid; Humans; Quinazolines; Riluzole; Xanthenes | 2013 |